ANB-012

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameANB-012
Drug Alias Nameanti-ActRIIB mAb program (AnaptysBio)ANB-012ANA-012ANA-12
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionActivin receptor type-2B inhibitors
TargetsActivin receptor type-2B
Therapy Area/IndicationsMuscular Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnaptysbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnaptysbio Inc
Active IndicationsN/A
Inactive IndicationsMuscular Atrophy

Other Information

ATC CodeN/A
Related LinksN/A